ChemicalBook CAS DataBase List 141790-23-0

141790-23-0

Hazard Information

Send Inquriy

Animal Model:	Specific pathogen-free cats at 6 months of age^[1]
Dosage:	45 mg/kg
Administration:	PO; twice daily; one day before FIV challenge for a total of six weeks
Result:	Effective at lowering plasma- and cell-associated viremia at two weeks post-feline immunodeficiency virus (FIV) infection with a trend toward lower plasma- and cell- associated viremia at four and six weeks post-infection (PI).